Moody Aldrich Partners LLC Reata Pharmaceuticals Inc Transaction History

Moody Aldrich Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$79.22 - $105.37 $158,756 - $211,161	2,004 Added 4.05%	51,533 $5.25 Million
Q1 2023 Apr 27, 2023	BUY	$30.85 - $93.17 $1.53 Million - $4.61 Million	49,529 New	49,529 $4.5 Million
Q3 2020 Nov 12, 2020	SELL	$93.53 - $163.34 $793,227 - $1.39 Million	-8,481 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$126.3 - $176.56 $142,719 - $199,512	1,130 Added 15.37%	8,481 $1.32 Million
Q1 2020 May 07, 2020	SELL	$124.16 - $247.74 $1.01 Million - $2.01 Million	-8,121 Reduced 52.49%	7,351 $1.06 Million
Q4 2019 Feb 07, 2020	BUY	$74.57 - $217.92 $1.15 Million - $3.37 Million	15,472 New	15,472 $3.16 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.